DXCM News and Press, DexCom Inc. From 04/28/22

DexCom, Inc. (DXCM) Q1 2022 Earnings Conference Call April 28, 2022 17:30 ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and Chief Executive Officer Jereme Sylvain - Chief Financial Officer Conference Call Participants Jeff Johnson - Baird Dani...

DexCom (NASDAQ:DXCM) on Thursday reported a mixed set of Q1 earnings, with non-GAAP EPS of $0.32 missing estimates by $0.20 but revenue of $628.8M beating expectations by $4.83M. The company reiterated its guidance for fiscal year 2022. Revenue is expected to be in the range of about $2.82B-$...

DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.m. (Eastern Time). The link to the webcast will be available on the DexCom, Inc. investor relations website at ...

DexCom press release (NASDAQ:DXCM): Q1 Non-GAAP EPS of $0.32 misses by $0.20. Revenue of $628.8M (+24.5% Y/Y) beats by $4.83M. Outlook: The company is reiterating guidance for fiscal year 2022: Revenue expected to be in the range of approximately $2.82 - 2.94 billion (15-20% growth), vs....

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2022. First Quarter 2022 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $628.8 million on a reported basis and 22% on an orga...

DexCom (NASDAQ:DXCM) is scheduled to announce Q1 earnings results on Thursday, April 28th, after market close. The consensus EPS Estimate is $0.52 (+57.6% Y/Y) and the consensus Revenue Estimate is $623.97M (+23.6% Y/Y). Over the last 2 years, DXCM has beaten EPS estimates 75% of the time and...

New portfolio of continuous glucose monitoring systems includes Dexcom ONE, Dexcom G6 and the upcoming Dexcom G7, which recently received CE Mark and is currently under FDA review 1 The expanded range of products offers the most innovative, connected and accessible CGM o...

In the stock market, past performance isn't a guarantee of future success. Still, it's worth considering investing in companies with a habit of beating the market. If said company can replicate the formula (or something close to it) that has made it successful in the past, it may still have...

Mid-cap stocks typically have established business models and can demonstrate strong growth because the law-of-large numbers has yet to kick in. That being the case, a high-quality, well-diversified, and low-cost mid-cap ETF can offer a solid way to bolster an investor's well-diversif...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Growth stocks were pressured as the Federal Reserve turne...